Sally Yang

Ms. Yang is an experienced regulatory professional with wide-ranging experience in drug development, including regulatory strategy development during pre-clinical and early clinical phases, IND and NDA filing, and Advisory Committee Meetings. Ms. Yang has spent more than 7 years in regulatory consulting, working with multidisciplinary teams, providing strategy and authoring support, as well as serving as program manager for global drug development programs, facilitating eCTD submissions, FDA interactions, and management of internal teams and external vendors. Ms. Yang is RAC certified in the US and holds a BS in Biology from Penn State University and a MS in Clinical and Regulatory affairs from Keck Graduate Institute.